NYSE:CLX - Clorox Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$164.52 -0.56 (-0.34 %)
(As of 12/14/2018 04:00 PM ET)
Previous Close$164.52
Today's Range$164.12 - $166.33
52-Week Range$113.57 - $167.70
Volume839,704 shs
Average Volume861,377 shs
Market Capitalization$21.07 billion
P/E Ratio26.28
Dividend Yield2.33%
Beta0.3
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands. It also provides charcoal products under the Kingsford and Match Light brands; bags, wraps, and containers under the Glad brand; cat litter products under the Fresh Step, Scoop Away, and Ever Clean brands; and digestive health products under the RenewLife brand. In addition, the company offers dressings and sauces primarily under the Hidden Valley, KC Masterpiece, Kingsford, and Soy Vay brands; water-filtration systems and filters under the Brita brand; natural personal care products under the Burt's Bees brand; and dietary supplements under the Rainbow Light, Natural Vitality, and Neocell brands. Further, it markets its products under the PinoLuz, Ayudin, Limpido, Clorinda, Poett, Mistolin, Lestoil, Bon Bril, Agua Jane, and Chux brands. The company sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, third-party and owned e-commerce channels, military stores, and distributors, as well as a direct sales force and medical supply distributors. The Clorox Company was founded in 1913 and is headquartered in Oakland, California.

Receive CLX News and Ratings via Email

Sign-up to receive the latest news and ratings for CLX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Polishes & sanitation goods
Sub-IndustryHousehold Products
SectorConsumer Staples
Current SymbolNYSE:CLX
Previous Symbol
CUSIP18905410
Phone510-271-7000

Debt

Debt-to-Equity Ratio3.38
Current Ratio1.07
Quick Ratio0.65

Price-To-Earnings

Trailing P/E Ratio26.28
Forward P/E Ratio26.07
P/E Growth4.05

Sales & Book Value

Annual Sales$6.12 billion
Price / Sales3.43
Cash Flow$7.6950 per share
Price / Cash Flow21.38
Book Value$5.67 per share
Price / Book29.02

Profitability

EPS (Most Recent Fiscal Year)$6.26
Net Income$823 million
Net Margins13.59%
Return on Equity102.65%
Return on Assets15.16%

Miscellaneous

Employees8,700
Outstanding Shares127,650,000
Market Cap$21.07 billion
OptionableOptionable

Clorox (NYSE:CLX) Frequently Asked Questions

What is Clorox's stock symbol?

Clorox trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLX."

How often does Clorox pay dividends? What is the dividend yield for Clorox?

Clorox announced a quarterly dividend on Tuesday, November 13th. Stockholders of record on Wednesday, January 23rd will be given a dividend of $0.96 per share on Friday, February 8th. This represents a $3.84 dividend on an annualized basis and a dividend yield of 2.33%. The ex-dividend date of this dividend is Tuesday, January 22nd. View Clorox's Dividend History.

How will Clorox's stock buyback program work?

Clorox announced that its Board of Directors has initiated a share buyback plan on Thursday, May 24th 2018, which allows the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy up to 12.6% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's board of directors believes its shares are undervalued.

How were Clorox's earnings last quarter?

Clorox Co (NYSE:CLX) posted its earnings results on Wednesday, October, 31st. The company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.59 by $0.03. The firm had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.53 billion. Clorox had a net margin of 13.59% and a return on equity of 102.65%. The business's revenue was up 4.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.46 EPS. View Clorox's Earnings History.

When is Clorox's next earnings date?

Clorox is scheduled to release their next quarterly earnings announcement on Friday, February 1st 2019. View Earnings Estimates for Clorox.

What guidance has Clorox issued on next quarter's earnings?

Clorox issued an update on its FY19 earnings guidance on Wednesday, October, 31st. The company provided earnings per share (EPS) guidance of $6.20-6.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.44. The company issued revenue guidance of +2-4% to ~$62.46-63.69 billion, compared to the consensus revenue estimate of $6.31 billion.Clorox also updated its FY 2019 guidance to $6.20-6.40 EPS.

What price target have analysts set for CLX?

13 equities research analysts have issued 1 year price objectives for Clorox's stock. Their forecasts range from $110.00 to $175.00. On average, they anticipate Clorox's stock price to reach $144.0769 in the next year. This suggests that the stock has a possible downside of 12.4%. View Analyst Price Targets for Clorox.

What is the consensus analysts' recommendation for Clorox?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clorox in the last year. There are currently 4 sell ratings, 7 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Clorox.

What are Wall Street analysts saying about Clorox stock?

Here are some recent quotes from research analysts about Clorox stock:
  • 1. According to Zacks Investment Research, "Clorox has outperformed the industry year to date owing to a robust surprise trend. First-quarter fiscal 2019 marked its eighth consecutive positive earnings surprise and fourth sales beat in the last six quarters. Earnings gained from lower tax rate, and higher sales and cost savings, while the Nutranext acquisition and higher volumes aided sales. Its 2020 Strategy, aimed at bolstering growth at various categories and market share, is also encouraging. However, the company trimmed its earnings guidance for fiscal 2019. This was mainly due to the expectations of making fewer share repurchases in fiscal 2019 than repurchases of nearly 50% of its $2-billion authorization, guided earlier. Adverse currency translations hurt the top-line growth and remain concerns in fiscal 2019. The company is also witnessing strained margins owing to higher commodity and logistics expenses, which is likely to persist in the fiscal year." (12/10/2018)
  • 2. Wells Fargo & Co analysts commented, "We’re not sure whether that’s due to a reduction in the dollar amount of share repurchases (CLX previously expected to repurchase ~$1B in FY19), or simply a mathematical function of shares trading near all­time highs. With shares strong into the print, gross margin questions remaining, and a guidance reduction, we expect shares to trade lower today." (10/31/2018)

Has Clorox been receiving favorable news coverage?

Media coverage about CLX stock has trended somewhat positive on Saturday, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Clorox earned a coverage optimism score of 0.7 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an effect on the stock's share price in the near term.

Who are some of Clorox's key competitors?

Who are Clorox's key executives?

Clorox's management team includes the folowing people:
  • Mr. Benno O. Dorer, Chairman & CEO (Age 54)
  • Mr. Kevin B. Jacobsen, Sr. VP & CFO (Age 52)
  • Ms. Dawn C. Willoughby, Exec. VP & COO (Age 49)
  • Ms. Laura Stein, Exec. VP of Corp. Affairs & Gen. Counsel (Age 56)
  • Ms. Linda Rendle, Exec. VP of Cleaning and Strategy (Age 40)

Who are Clorox's major shareholders?

Clorox's stock is owned by many different of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (12.23%), Vanguard Group Inc (12.23%), BlackRock Inc. (7.68%), Morgan Stanley (2.40%), Renaissance Technologies LLC (1.83%) and Bank of New York Mellon Corp (1.30%). Company insiders that own Clorox stock include Benno O Dorer, Dawn C Willoughby, Denise Garner, Diego J Barral, James E Foster, Jeff Baker, Jon M Balousek, Laura Stein, Linda J Rendle, Matthew T Laszlo and Michael R Costello. View Institutional Ownership Trends for Clorox.

Which major investors are selling Clorox stock?

CLX stock was sold by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, Unigestion Holding SA, Deutsche Bank AG, Macquarie Group Ltd., AQR Capital Management LLC, Mitsubishi UFJ Trust & Banking Corp, Acadian Asset Management LLC and Janus Henderson Group PLC. Company insiders that have sold Clorox company stock in the last year include Benno O Dorer, Dawn C Willoughby, Denise Garner, Diego J Barral, Jeff Baker, Jon M Balousek, Laura Stein, Linda J Rendle, Matthew T Laszlo and Michael R Costello. View Insider Buying and Selling for Clorox.

Which major investors are buying Clorox stock?

CLX stock was purchased by a variety of institutional investors in the last quarter, including Morgan Stanley, DekaBank Deutsche Girozentrale, Bank of New York Mellon Corp, Legal & General Group Plc, JPMorgan Chase & Co., Bank of Montreal Can, Putnam Investments LLC and Vanguard Group Inc. View Insider Buying and Selling for Clorox.

How do I buy shares of Clorox?

Shares of CLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Clorox's stock price today?

One share of CLX stock can currently be purchased for approximately $164.52.

How big of a company is Clorox?

Clorox has a market capitalization of $21.07 billion and generates $6.12 billion in revenue each year. The company earns $823 million in net income (profit) each year or $6.26 on an earnings per share basis. Clorox employs 8,700 workers across the globe.

What is Clorox's official website?

The official website for Clorox is http://www.thecloroxcompany.com.

How can I contact Clorox?

Clorox's mailing address is 1221 BROADWAY, OAKLAND CA, 94612. The company can be reached via phone at 510-271-7000 or via email at [email protected]


MarketBeat Community Rating for Clorox (NYSE CLX)

Community Ranking:  1.4 out of 5 (star)
Outperform Votes:  243 (Vote Outperform)
Underperform Votes:  637 (Vote Underperform)
Total Votes:  880
MarketBeat's community ratings are surveys of what our community members think about Clorox and other stocks. Vote "Outperform" if you believe CLX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/15/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel